Search Results 411-420 of 18506 for crohn's disease
Mayo Clinic School of Graduate Medical Education offers the one-year Inflammatory Bowel Disease Fellowship in Rochester, Minnesota.
This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...
A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) ... and stage of disease, and previous treatments or health ...
Carry a gene for a hereditary colon cancer syndrome; Have a history of inflammatory bowel disease, such as ulcerative colitis or Crohn's disease.
... during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced ...
Studies cover a wide range of areas, including pouch-related complications of the surgery, such as pouchitis, Crohn's disease of the pouch and Clostridioides ...
Crohn's disease, an inflammatory bowel disease that most often begins gradually but can worsen over time. Symptoms can include diarrhea, abdominal pain and ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Crohn's disease is an inflammatory bowel disease featured image. Crohn's disease is an inflammatory bowel disease. Dana Sparks. September 27, 2018. Mayo ...
The purpose of this study is to test the effectiveness and safety of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.